Arwa Saidi

Arwa Saidi, MEd, MBBCH

Professor

Department: MD-COGNITAL HRT CTR EXCELLENCE
Business Phone: (352) 273-7770
Business Email: asaidi@ufl.edu

About Arwa Saidi

 Arwa Saidi, MEd, MBBCH, FAAP, FACC, is board-certified in internal medicine, pediatrics and pediatric cardiology. Dr. Saidi received her medical degree from the Royal College of Surgeons in Dublin. She then completed a residency in pediatrics and internal medicine at Baylor College of Medicine in Houston. 

Throughout her professional career, Dr. Saidi has served in multiple positions involving pediatric and adult congenital heart care. Since 2003, Dr. Saidi has served as the co-director of the adult congenital heart program at the UF Health Congenital Heart Center. 

She is a fellow and an active member of the American College of Cardiology, and serves on the Medical Advisory Board of the Adult Congenital Heart Association.  

Her clinical interests include adult congenital heart disease and transitional care.

Accomplishments

Exemplary Teacher Award
2011 · University of Florida
Teaching award
2009 · University of Florida Pediatric Residency
Teaching award
2007 · University of Florida Pediatric Residency

Board Certifications

  • Adult Congenital Heart Disease
    American Board of Internal Medicine
  • Internal Medicine
    American Board of Internal Medicine
  • Pediatric Cardiology
    American Board of Pediatrics
  • Pediatrics
    American Board of Pediatrics

Clinical Profile

Specialties
  • Medicine
  • Pediatrics
Subspecialties
  • Cardiology
  • Pediatric Cardiology
Areas of Interest
  • Congenital heart disease

Publications

2021
Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children.
Circulation. 143(1):78-88 [DOI] 10.1161/CIRCULATIONAHA.120.049836. [PMID] 33166178.
2020
Coronavirus Disease 2019 (COVID-19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease.
Journal of the American Heart Association. 9(12) [DOI] 10.1161/JAHA.120.017224. [PMID] 32441586.
2019
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Circulation. 139(14):E698-E800 [DOI] 10.1161/CIR.0000000000000603.
2019
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Journal of the American College of Cardiology. 73(12):e81-e192 [DOI] 10.1016/j.jacc.2018.08.1029. [PMID] 30121239.
2019
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Journal of the American College of Cardiology. 73(12):1494-1563 [DOI] 10.1161/CIR.0000000000000602.
2019
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Journal of the American College of Cardiology. 73(12):1494-1563 [DOI] 10.1016/j.jacc.2018.08.1028. [PMID] 30121240.
2019
Development of a predictive model for drug-associated QT prolongation in the inpatient setting using electronic health record data.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 76(14):1059-1070 [DOI] 10.1093/ajhp/zxz100. [PMID] 31185072.
2018
Cardiovascular Health in Turner Syndrome: A Scientific Statement from the American Heart Association
Circulation-Genomic and Precision Medicine. 11(10) [DOI] 10.1161/HCG.0000000000000048. [PMID] 30354301.
2018
Pregnancy in Congenital Heart Disease: A Review for the General Cardiologist
Cardiovascular Innovations and Applications. 3(1):31-39 [DOI] 10.15212/CVIA.2017.0047.
2017
Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease: A Scientific Statement From the American Heart Association.
Circulation. 136(20):e348-e392 [DOI] 10.1161/CIR.0000000000000535. [PMID] 28993401.
2017
University- Versus Community-Based Residency Programs: Does the Distinction Matter?
Journal of graduate medical education. 9(4):426-429 [DOI] 10.4300/JGME-D-16-00579.1. [PMID] 28824753.
2015
2015 SPCTPD/ACC/AAP/AHA Training Guidelines for Pediatric Cardiology Fellowship Programs (Revision of the 2005 Training Guidelines for Pediatric Cardiology Fellowship Programs).
Journal of the American College of Cardiology. [DOI] 10.1016/j.jacc.2015.03.004. [PMID] 25777637.
2015
Artefactual atrial flutter due to interference from a portable media device.
Cardiology in the young. 25(7):1375-6 [DOI] 10.1017/S1047951115001080. [PMID] 26081903.
2015
Task Force 6: Pediatric Cardiology Fellowship Training in Adult Congenital Heart Disease.
Journal of the American College of Cardiology. 66(6):723-31 [DOI] 10.1016/j.jacc.2015.03.011. [PMID] 25777632.
2015
Task Force 6: Pediatric Cardiology Fellowship Training in Adult Congenital Heart Disease. SPCTPD/ACC/AAP/AHA.
Circulation. 132(6):e91-8 [DOI] 10.1161/CIR.0000000000000197. [PMID] 25769638.
2014
Transition in congenital heart disease: it takes a village.
Heart (British Cardiac Society). 100(14):1075-6 [DOI] 10.1136/heartjnl-2014-306030. [PMID] 24855319.
2012
An algorithm to identify preterm infants in administrative claims data.
Pharmacoepidemiology and drug safety. 21(6):640-50 [DOI] 10.1002/pds.3264. [PMID] 22504840.
2012
Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study.
BMJ (Clinical research ed.). 345 [DOI] 10.1136/bmj.e4627. [PMID] 22809800.
2012
Methodological Concerns Regarding Cost-effectiveness Analysis of Palivizumab in Florida Medicaid-Reply.
Archives of pediatrics & adolescent medicine. 166(10):968-70 [DOI] 10.1001/archpediatrics.2012.1594. [PMID] 23753905.
2012
Transition of care: what is the pediatric hospitalist’s role? An exploratory survey of current attitudes.
Journal of hospital medicine. 7(4):277-81 [DOI] 10.1002/jhm.936. [PMID] 22125023.
2011
Age-Dependent Effectiveness of Rsv Immunoprophylaxis
Pharmacoepidemiology and Drug Safety. 20
2011
Best practices in managing transition to adulthood for adolescents with congenital heart disease: the transition process and medical and psychosocial issues: a scientific statement from the American Heart Association.
Circulation. 123(13):1454-85 [DOI] 10.1161/CIR.0b013e3182107c56. [PMID] 21357825.
2011
Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications.
Archives of pediatrics & adolescent medicine. 165(6):498-505 [DOI] 10.1001/archpediatrics.2010.298. [PMID] 21300647.
2011
Parental knowledge regarding lifelong congenital cardiac care.
Pediatrics. 128(6):e1489-95 [DOI] 10.1542/peds.2010-3068. [PMID] 22123874.
2010
Comparison of Rsv Seasonality in Four States
American Journal of Epidemiology. 171
2010
Latitude as a Factor in Rsv Epidemiology in Florida
American Journal of Epidemiology. 171
2010
Palivizumab utilization and compliance: trends in respiratory syncytial virus prophylaxis in Florida.
The Journal of pediatrics. 156(6):953-959.e1 [DOI] 10.1016/j.jpeds.2009.12.016. [PMID] 20223478.
2010
Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHD.
Pharmacoepidemiology and drug safety. 19(5):457-64 [DOI] 10.1002/pds.1931. [PMID] 20232490.
2010
The Interdisciplinary Collaborative On Health and Education Transition (Ichet): Integrating Three Worlds in the Transition of Youth With Chronic Illness
Pediatric Pulmonology.
2009
Attitude toward and current practice of transfer and transition of adolescents with congenital heart disease in the United States of America and Europe.
Pediatric cardiology. 30(6):786-93 [DOI] 10.1007/s00246-009-9442-1. [PMID] 19365651.
2009
Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD.
Pediatrics. 124(1):e75-80 [DOI] 10.1542/peds.2008-3138. [PMID] 19564272.
2009
Cost-Effectiveness of Respiratory Syncytial Virus Prophylaxis With Palivizumab From the Perspective of a Southern Us Medicaid Agency
Value in Health. 12(7):A301-A302 [DOI] 10.1016/S1098-3015(10)74479-X.
2009
Depression and anxiety in adult congenital heart disease: predictors and prevalence.
International journal of cardiology. 137(2):158-64 [DOI] 10.1016/j.ijcard.2008.06.042. [PMID] 18707776.
2009
Developing a transition program from pediatric- to adult-focused cardiology care: practical considerations.
Congenital heart disease. 4(4):204-15 [DOI] 10.1111/j.1747-0803.2009.00312.x. [PMID] 19664023.
2009
Effectiveness of palivizumab prophylaxis in infants and children in Florida.
Pharmacoepidemiology and drug safety. 18:S97-S98
2009
Effects of Preexisting Cardiovascular Risk Factors On Initiation of Stimulants in Adults Newly Diagnosed With Adhd
Pharmacoepidemiology and Drug Safety. 18
2009
Transition and transfer from pediatric to adult care of young adults with complex congenital heart disease.
Current cardiology reports. 11(4):291-7 [PMID] 19563729.
View on: PubMed
2008
Palivizumab Utilization and Compliance With Recommendations in Florida
Pharmacoepidemiology and Drug Safety. 17
2008
Role of Age in Respiratory Syncycial Virus Infection Risk – Recommendations for Palivizumab Utilization
Pharmacoepidemiology and Drug Safety. 17
2008
Transient ventricular dysfunction after an asphyxiation event: stress or hypoxia?
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 9(6):e47-50 [DOI] 10.1097/PCC.0b013e31818e370e. [PMID] 18997592.
2008
Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
The Annals of pharmacotherapy. 42(1):24-31 [PMID] 18042808.
View on: PubMed
2007
Biomedical and psychosocial evaluation of “cured” adults with congenital heart disease.
Congenital heart disease. 2(1):44-54 [DOI] 10.1111/j.1747-0803.2007.00071.x. [PMID] 18377516.
2007
Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
Pediatrics. 120(6):e1494-501 [PMID] 18055666.
View on: PubMed
2006
Implantable cardioverter defibrillator implant-explant-implant case study: addressing the psychological adjustment to multiple shocks.
Clinical cardiology. 29(6):274-6 [PMID] 16796079.
View on: PubMed
2006
The role of the psychologist in adult congenital heart disease.
Cardiology clinics. 24(4):607-18, vi [PMID] 17098514.
View on: PubMed
2005
An institutional review of the value of computed tomographic angiography in the diagnosis of congenital cardiac malformations.
Cardiology in the young. 15(1):47-51 [PMID] 15831161.
View on: PubMed
2005
Biopsychosocial experiences of adults with congenital heart disease: review of the literature.
American heart journal. 150(2):193-201 [PMID] 16086917.
View on: PubMed
1998
Outcome of pregnancy following intervention for coarctation of the aorta.
The American journal of cardiology. 82(6):786-8 [PMID] 9761091.
View on: PubMed

Education

Fellowship
1994-1997 · Baylor College of Medicine
Residency – Internal Medicine, Pediatrics
1990-1994 · Baylor College of Medicine
Medical Degree
1988 · Royal College of Surgeons

Teaching Profile

Courses Taught
2018
MDC7400 Pediatric Clerkship

Contact Details

Phones:
Business:
(352) 273-7770
Emails:
Business:
asaidi@ufl.edu